The Toronto company raised a Series A co-led by OrbiMed and Qiming Venture Partners USA for AI that reads trial…
The REDCap Cloud maker says its new platform moves raw trial data to submission-ready files in weeks.
Superluminal Medicines banks $60M to take its AI-designed MC4R obesity drug into Phase 1.
Seoul St. Mary's Hospital built in-house AI that screens myeloma patients for trial eligibility in seconds.
Draft posters for Generate Biomedicines' AI-built asthma antibody hit the ERS site weeks before the embargo lifted.
Agentic AI platform for clinical development closes a $37.3M Series B led by Merck's health fund and S32.
FDA centers lay out a three-stage evidence path for wearable and sensor trial endpoints.
TCS launches an agentic AI hub that brings governed agents to clinical trials and drug safety work.